FDA's radiology GMP soon
This article was originally published in Clinica
Executive Summary
The FDA's Center for Drug Evaluation and Research will soon disclose its latest attempt at drafting good manufacturing practice regulations for the radioisotopes used in positron emission tomography. The GMP programme was mandated as part of the FDA Modernization Act of 1997, but coming up with a draft that pleased industry has been challenging.